June 28, 2016 / 8:12 PM / a year ago

BRIEF-Hemostemix says Criterium notified it has terminated master services agreement

June 28 (Reuters) - Hemostemix Inc :

* Criterium notified co it has terminated master services agreement dated June 7, 2014 relating to clinical research services

* Hemostemix is placing a temporary hold on enrollment for its phase 2 clinical trials in canada and south africa

* Criterium will no longer be providing any services for hemostemix phase 2 clinical trials

* Currently evaluating its options as to how it will continue with clinical trials and to ensure patient follow up

* Hemostemix has made decision to temporarily cease enrolling any new patients into trial

* With respect to previously announced private placement financing, Hemostemix announces financing is proceeding

* Structure of offering may be amended to include a combination of equity and debt Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below